Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli.

Wang W, Huang B, Jiang T, Wang X, Qi X, Gao Y, Tan W, Ruan L.

PLoS One. 2012;7(12):e52488. doi: 10.1371/journal.pone.0052488. Epub 2012 Dec 21.

PMID:
23285063
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.

Ebrahimi SM, Dabaghian M, Tebianian M, Jazi MH.

Virology. 2012 Aug 15;430(1):63-72. doi: 10.1016/j.virol.2012.04.015. Epub 2012 May 16.

PMID:
22595444
[PubMed - indexed for MEDLINE]
Free Article
3.

Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.

Shim BS, Choi YK, Yun CH, Lee EG, Jeon YS, Park SM, Cheon IS, Joo DH, Cho CH, Song MS, Seo SU, Byun YH, Park HJ, Poo H, Seong BL, Kim JO, Nguyen HH, Stadler K, Kim DW, Hong KJ, Czerkinsky C, Song MK.

PLoS One. 2011;6(11):e27953. doi: 10.1371/journal.pone.0027953. Epub 2011 Nov 30.

PMID:
22140491
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ.

Vaccine. 2008 Jan 10;26(2):201-14. Epub 2007 Nov 20.

PMID:
18063235
[PubMed - indexed for MEDLINE]
5.

Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.

Huang B, Wang W, Li R, Wang X, Jiang T, Qi X, Gao Y, Tan W, Ruan L.

Virol J. 2012 Dec 29;9:322. doi: 10.1186/1743-422X-9-322.

PMID:
23272943
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.

Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT.

J Gen Virol. 2002 Aug;83(Pt 8):1851-9.

PMID:
12124449
[PubMed - indexed for MEDLINE]
Free Article
7.

Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.

Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.

Vaccine. 2011 Jul 26;29(33):5481-7. doi: 10.1016/j.vaccine.2011.05.062. Epub 2011 Jun 12.

PMID:
21664216
[PubMed - indexed for MEDLINE]
8.

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.

Soboleski MR, Gabbard JD, Price GE, Misplon JA, Lo CY, Perez DR, Ye J, Tompkins SM, Epstein SL.

PLoS One. 2011;6(7):e21937. doi: 10.1371/journal.pone.0021937. Epub 2011 Jul 15.

PMID:
21789196
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice.

Wang L, Wang YC, Feng H, Ahmed T, Compans RW, Wang BZ.

Biomed Res Int. 2013;2013:686549. doi: 10.1155/2013/686549. Epub 2013 Jul 30.

PMID:
23984396
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.

Zhao G, Du L, Xiao W, Sun S, Lin Y, Chen M, Kou Z, He Y, Lustigman S, Jiang S, Zheng BJ, Zhou Y.

Vaccine. 2010 Oct 18;28(44):7233-40. doi: 10.1016/j.vaccine.2010.08.049. Epub 2010 Aug 21.

PMID:
20732469
[PubMed - indexed for MEDLINE]
11.

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

Eliasson DG, El Bakkouri K, Schön K, Ramne A, Festjens E, Löwenadler B, Fiers W, Saelens X, Lycke N.

Vaccine. 2008 Feb 26;26(9):1243-52. doi: 10.1016/j.vaccine.2007.12.027. Epub 2008 Jan 10.

PMID:
18243429
[PubMed - indexed for MEDLINE]
12.

Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.

Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.

J Virol Methods. 2008 Dec;154(1-2):121-7. doi: 10.1016/j.jviromet.2008.08.011. Epub 2008 Sep 27.

PMID:
18789973
[PubMed - indexed for MEDLINE]
13.

[Construction, expression and immunogenicity analysis of a fusion protein containing M2e of influenza A virus fused to a modified Pseudomonas aeruginosa exotoxin A].

Xu Y, Yao LH, Chen AJ, Guo JQ, Liu XY, Bo H, Liu LQ, Shu YL, Zhang ZQ.

Bing Du Xue Bao. 2010 May;26(3):189-94. Chinese.

PMID:
20572339
[PubMed - indexed for MEDLINE]
14.

Characterization of immunity induced by M2e of influenza virus.

Wu F, Huang JH, Yuan XY, Huang WS, Chen YH.

Vaccine. 2007 Dec 17;25(52):8868-73. Epub 2007 Oct 22.

PMID:
18061317
[PubMed - indexed for MEDLINE]
15.

[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].

Stepanova LA, Kovaleva AA, Potapchuk MV, Korotkov AV, Kupriianov VV, Blokhina EA, Kotliarov RIu, Tsybalova LM.

Vopr Virusol. 2013 May-Jun;58(3):21-5. Russian.

PMID:
24006628
[PubMed - indexed for MEDLINE]
16.

An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge.

Ma JH, Yang FR, Yu H, Zhou YJ, Li GX, Huang M, Wen F, Tong G.

Virol J. 2013 Jul 9;10:227. doi: 10.1186/1743-422X-10-227.

PMID:
23834899
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice.

Alvarez P, Zylberman V, Ghersi G, Boado L, Palacios C, Goldbaum F, Mattion N.

Vaccine. 2013 Jan 21;31(5):806-12. doi: 10.1016/j.vaccine.2012.11.072. Epub 2012 Dec 27.

PMID:
23246552
[PubMed - indexed for MEDLINE]
18.

Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.

Staneková Z, Király J, Stropkovská A, Mikušková T, Mucha V, Kostolanský F, Varečková E.

Acta Virol. 2011;55(1):61-7.

PMID:
21434706
[PubMed - indexed for MEDLINE]
19.

Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.

Hashemi H, Pouyanfard S, Bandehpour M, Noroozbabaei Z, Kazemi B, Saelens X, Mokhtari-Azad T.

PLoS One. 2012;7(9):e45765. doi: 10.1371/journal.pone.0045765. Epub 2012 Sep 24.

PMID:
23029232
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

El Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, Birkett A, Van Rooijen N, Verbeek S, Fiers W, Saelens X.

J Immunol. 2011 Jan 15;186(2):1022-31. doi: 10.4049/jimmunol.0902147. Epub 2010 Dec 17.

PMID:
21169548
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk